Literature DB >> 31767144

Effects of oxygen on post-surgical infections during an individualised perioperative open-lung ventilatory strategy: a randomised controlled trial.

Carlos Ferrando1, César Aldecoa2, Carmen Unzueta3, F Javier Belda4, Julián Librero5, Gerardo Tusman6, Fernando Suárez-Sipmann7, Salvador Peiró8, Natividad Pozo4, Andrea Brunelli9, Ignacio Garutti10, Clara Gallego11, Aurelio Rodríguez12, Jose Ignacio García13, Oscar Díaz-Cambronero14, Jaume Balust15, Francisco J Redondo16, Manuel de la Matta17, Lucía Gallego-Ligorit18, Javier Hernández19, Pascual Martínez20, Ana Pérez21, Sonsoles Leal22, Enrique Alday23, Pablo Monedero24, Rafael González25, Guido Mazzirani26, Gerardo Aguilar4, Manuel López-Baamonde15, Mar Felipe3, Ana Mugarra4, Jara Torrente27, Lucia Valencia12, Viviana Varón13, Sergio Sánchez16, Benigno Rodríguez22, Ana Martín25, Inmaculada India3, Gonzalo Azparren3, Rodrigo Molina13, Jesús Villar28, Marina Soro4.   

Abstract

BACKGROUND: We aimed to examine whether using a high fraction of inspired oxygen (FIO2) in the context of an individualised intra- and postoperative open-lung ventilation approach could decrease surgical site infection (SSI) in patients scheduled for abdominal surgery.
METHODS: We performed a multicentre, randomised controlled clinical trial in a network of 21 university hospitals from June 6, 2017 to July 19, 2018. Patients undergoing abdominal surgery were randomly assigned to receive a high (0.80) or conventional (0.3) FIO2 during the intraoperative period and during the first 3 postoperative hours. All patients were mechanically ventilated with an open-lung strategy, which included recruitment manoeuvres and individualised positive end-expiratory pressure for the best respiratory-system compliance, and individualised continuous postoperative airway pressure for adequate peripheral oxyhaemoglobin saturation. The primary outcome was the prevalence of SSI within the first 7 postoperative days. The secondary outcomes were composites of systemic complications, length of intensive care and hospital stay, and 6-month mortality.
RESULTS: We enrolled 740 subjects: 371 in the high FIO2 group and 369 in the low FIO2 group. Data from 717 subjects were available for final analysis. The rate of SSI during the first postoperative week did not differ between high (8.9%) and low (9.4%) FIO2 groups (relative risk [RR]: 0.94; 95% confidence interval [CI]: 0.59-1.50; P=0.90]). Secondary outcomes, such as atelectasis (7.7% vs 9.8%; RR: 0.77; 95% CI: 0.48-1.25; P=0.38) and myocardial ischaemia (0.6% [n=2] vs 0% [n=0]; P=0.47) did not differ between groups.
CONCLUSIONS: An oxygenation strategy using high FIO2 compared with conventional FIO2 did not reduce postoperative SSIs in abdominal surgery. No differences in secondary outcomes or adverse events were found. CLINICAL TRIAL REGISTRATION: NCT02776046.
Copyright © 2019 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  anaesthesia; inspiratory oxygen fraction; positive end-expiratory pressure; postoperative complications; recruitment manoeuvres; sepsis; surgery; surgical site infection

Mesh:

Substances:

Year:  2019        PMID: 31767144     DOI: 10.1016/j.bja.2019.10.009

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  Does Higher Intraoperative Fraction of Inspired Oxygen Improve Complication Rates Following Implant-Based Breast Reconstruction?

Authors:  Mallory A Rowley; Kometh Thawanyarat; Jennifer K Shah; Lawrence Cai; Elizabeth Turner; Oscar J Manrique; Brian Thornton; Rahim Nazerali
Journal:  Aesthet Surg J Open Forum       Date:  2022-05-07

Review 2.  Oxygen therapy for critically Ill and post-operative patients.

Authors:  Paul J Young; Daniel Frei
Journal:  J Anesth       Date:  2021-09-06       Impact factor: 2.078

Review 3.  Fraction of inspired oxygen during general anesthesia for non-cardiac surgery: Systematic review and meta-analysis.

Authors:  Maria Høybye; Peter C Lind; Mathias J Holmberg; Maria Bolther; Marie K Jessen; Mikael F Vallentin; Frederik B Hansen; Johanne M Holst; Andreas Magnussen; Niklas S Hansen; Cecilie M Johannsen; Johannes Enevoldsen; Thomas H Jensen; Lara L Roessler; Maibritt P Klitholm; Mark A Eggertsen; Philip Caap; Caroline Boye; Karol M Dabrowski; Lasse Vormfenne; Jeppe Henriksen; Mathias Karlsson; Ida R Balleby; Marie S Rasmussen; Kim Paelestik; Asger Granfeldt; Lars W Andersen
Journal:  Acta Anaesthesiol Scand       Date:  2022-06-23       Impact factor: 2.274

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.